[
  {
    "ts": null,
    "headline": "Pfizer Inc. stock rises Friday, still underperforms market",
    "summary": "Pfizer Inc. stock rises Friday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=7f0eb968c2786057ccdf15c713b5670aee61366a9eb2c436ffd8c517eda2f78e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740760560,
      "headline": "Pfizer Inc. stock rises Friday, still underperforms market",
      "id": 132958390,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock rises Friday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=7f0eb968c2786057ccdf15c713b5670aee61366a9eb2c436ffd8c517eda2f78e"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Pflash: A Spotlight on Antibody-Drug Conjugates (ADCs) Transcript",
    "summary": "REFINITIV STREETEVENTS EDITED TRANSCRIPT PFE.N - Pfizer Pflash: A Spotlight On Antibody-Drug Conjugates EVENT...",
    "url": "https://finnhub.io/api/news?id=a048b550fa347639980f5260033ff7fd0f1feb7aa3e07e80547940d64546e2b0",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740733647,
      "headline": "Pfizer Pflash: A Spotlight on Antibody-Drug Conjugates (ADCs) Transcript",
      "id": 132905490,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "REFINITIV STREETEVENTS EDITED TRANSCRIPT PFE.N - Pfizer Pflash: A Spotlight On Antibody-Drug Conjugates EVENT...",
      "url": "https://finnhub.io/api/news?id=a048b550fa347639980f5260033ff7fd0f1feb7aa3e07e80547940d64546e2b0"
    }
  },
  {
    "ts": null,
    "headline": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "summary": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "url": "https://finnhub.io/api/news?id=9cbf52ef07edbc5bfcfb2610a217677b7f12f0522f3e65f5864ff7326854f3b8",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740726000,
      "headline": "Drug Stocks Are the New Safe Bet in a Shaky Market",
      "id": 132907806,
      "image": "",
      "related": "PFE",
      "source": "DowJones",
      "summary": "Drug Stocks Are the New Safe Bet in a Shaky Market",
      "url": "https://finnhub.io/api/news?id=9cbf52ef07edbc5bfcfb2610a217677b7f12f0522f3e65f5864ff7326854f3b8"
    }
  },
  {
    "ts": null,
    "headline": "UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older",
    "summary": "Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 years and older. The shot, branded as mRESVIA, is for the...",
    "url": "https://finnhub.io/api/news?id=8931ea4c1d016024fa1a731be17edd7f899cd3e6e1cdad182175e4c7d5e24da6",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740722952,
      "headline": "UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older",
      "id": 132904329,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 years and older. The shot, branded as mRESVIA, is for the...",
      "url": "https://finnhub.io/api/news?id=8931ea4c1d016024fa1a731be17edd7f899cd3e6e1cdad182175e4c7d5e24da6"
    }
  }
]